News

Pharmabiz8h
argenx SE highlights VYVGART data setting new standard in efficacy and improved quality of life measures for patients with gMG and CIDP
Amsterdam, the Netherlands Thursday, April 10, 2025, 18:00 Hrs [IST] ...
Pharmabiz9h
US FDA inspects Science 37’s Direct-to-Patient Site for clinical research in phase 3 asthma trial; no objectionable conditions noted
US FDA inspects Science 37’s Direct-to-Patient Site for clinical research in phase 3 asthma trial; no objectionable conditions noted: Morrisville, N.C. Thursday, April 10, 2025, ...
Pharmabiz10h
Bayer seeks EMA approval for aflibercept 8 mg for treatment of retinal vein occlusion
Bayer seeks EMA approval for aflibercept 8 mg for treatment of retinal vein occlusion: Berlin Thursday, April 10, 2025, 16:00 Hrs [IST] Bayer has submitted an application to the E ...
Pharmabiz10h
OneSource’s unit 2 facility in Bengaluru gets Brazilian Health Regulatory Agency approval
OneSource’s unit 2 facility in Bengaluru gets Brazilian Health Regulatory Agency approval: Our Bureau, Mumbai Thursday, April 10, 2025, 15:50 Hrs [IST] OneSource Specialty Pharm ...
Pharmabiz11h
AstraZeneca to showcase innovation in infectious disease protection at ESCMID Global 2025
AstraZeneca to showcase innovation in infectious disease protection at ESCMID Global 2025: Cambridge, UK Thursday, April 10, 2025, 15:00 Hrs [IST] AstraZeneca will share new data ...
Pharmabiz12h
Nyxoah updates on US FDA approvable letter for Genio system to treat obstructive sleep apnea
Nyxoah updates on US FDA approvable letter for Genio system to treat obstructive sleep apnea: Mont-Saint-Guibert, Belgium Thursday, April 10, 2025, 14:00 Hrs [IST] Nyxoah SA, a me ...
Pharmabiz13h
Avidity Biosciences receives Japan MHLW’s orphan drug status for delpacibart etedesiran to treat myotonic dystrophy type 1
Avidity Biosciences receives Japan MHLW’s orphan drug status for delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Thursday, April 10, 2025, 13:00 Hrs [IST] A ...
Pharmabiz14h
Logistics4Pharma expands customs services with temporary storage and transit document management
Logistics4Pharma expands customs services with temporary storage and transit document management: Frankfurt Thursday, April 10, 2025, 12:00 Hrs [IST] Logistics4Pharma, a Frankfurt ...
Pharmabiz16h
Sanofi announces tolebrutinib phase 3 study data published in NEJM shows benefit on disability progression in multiple sclerosis
Sanofi announces tolebrutinib phase 3 study data published in NEJM shows benefit on disability progression in multiple sclerosis: Paris Thursday, April 10, 2025, 10:00 Hrs [IST] T ...
Pharmabiz16h
CPHI Americas launches badge to empower rising pharma talent
CPHI Americas 2025, which is committed to empowering the next generation of pharmaceutical professionals, and has announced a new Emerging Professional badge, offering learning, networking, and career ...
Pharmabiz18h
HDDA alleges 30 % of medical shops in rural areas of Haryana are run by unqualified people
Peethaambaran Kunnathoor, Chennai Thursday, April 10, 2025, 08:00 Hrs [IST] ...
Pharmabiz18h
Indian lifesciences sector perceives tech & collaboration will propel rapid turnaround in drug discovery & clinical trials
Indian lifesciences sector perceives tech & collaboration will propel rapid turnaround in drug discovery & clinical trials: Nandita Vijayasimha, Bengaluru Thursday, April 10, 2025 ...